{
  "trial_id": "NCT00367601",
  "trial_group": "cancer",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, ECOG Performance Status, histological subtype, stage of disease, prior radiation therapy, prior use of EGFR inhibitor or antiangiogenic agent, measurable disease status, contraception use, pregnancy status, breastfeeding status, evidence of bleeding diathesis or coagulopathy, evidence of central nervous system involvement or brain metastases, history of major surgical procedures, history of abdominal fistula or gastrointestinal perforation, presence of serious non-healing wounds or ulcers, history of hemoptysis, presence of clinically significant infections, presence of other active malignancy.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "gender"
        ],
        [
          "Investigator Assigned Performance Status",
          "ECOG Performance Status"
        ],
        [
          "Stage",
          "stage of disease"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Race (NIH/OMB)",
        "Region of Enrollment",
        "Patient-Reported Performance Status",
        "Smoking Status"
      ],
      "remaining_candidate_features": [
        "histological subtype",
        "prior radiation therapy",
        "prior use of EGFR inhibitor or antiangiogenic agent",
        "measurable disease status",
        "contraception use",
        "pregnancy status",
        "breastfeeding status",
        "evidence of bleeding diathesis or coagulopathy",
        "evidence of central nervous system involvement or brain metastases",
        "history of major surgical procedures",
        "history of abdominal fistula or gastrointestinal perforation",
        "presence of serious non-healing wounds or ulcers",
        "history of hemoptysis",
        "presence of clinically significant infections",
        "presence of other active malignancy"
      ]
    }
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, ECOG Performance Status, Histological subtype, Stage of disease, Prior radiation therapy, Measurable disease according to RECIST,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "Investigator Assigned Performance Status",
          "ECOG Performance Status"
        ],
        [
          "Stage",
          "Stage of disease"
        ]
      ],
      "remaining_reference_features": [
        "Race (NIH/OMB)",
        "Patient-Reported Performance Status",
        "Smoking Status"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Histological subtype",
        "Prior radiation therapy",
        "Measurable disease according to RECIST"
      ]
    }
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, ECOG Performance Status, Histology, Stage of disease, Prior radiation therapy, Prior use of EGFR inhibitor or antiangiogenic agent, Measurable disease according to RECIST.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "Investigator Assigned Performance Status",
          "ECOG Performance Status"
        ],
        [
          "Stage",
          "Stage of disease"
        ]
      ],
      "remaining_reference_features": [
        "Race (NIH/OMB)",
        "Patient-Reported Performance Status",
        "Smoking Status"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Histology",
        "Prior radiation therapy",
        "Prior use of EGFR inhibitor or antiangiogenic agent",
        "Measurable disease according to RECIST."
      ]
    }
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ECOG Performance Status, histology, stage of disease, presence of pleural effusion, prior radiation therapy, measurable disease according to RECIST.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race (NIH/OMB)",
          "race"
        ],
        [
          "Investigator Assigned Performance Status",
          "ECOG Performance Status"
        ],
        [
          "Stage",
          "stage of disease"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Region of Enrollment",
        "Patient-Reported Performance Status",
        "Smoking Status"
      ],
      "remaining_candidate_features": [
        "histology",
        "presence of pleural effusion",
        "prior radiation therapy",
        "measurable disease according to RECIST."
      ]
    }
  }
}